These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28984386)

  • 1. Pyogenic liver abscess related to intrahepatic bile duct stones: Difficulties in infectious control and diagnosis of concomitant cholangiocarcinoma.
    Shi SH; Feng XN; Wang ZY; Sun K; Xu JF; Kong HS; Zheng SS
    J Gastroenterol Hepatol; 2018 May; 33(5):1092-1099. PubMed ID: 28984386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyogenic Liver Abscess of Biliary Origin: The Existing Problems and Their Strategies.
    Shi SH; Zhai ZL; Zheng SS
    Semin Liver Dis; 2018 Aug; 38(3):270-283. PubMed ID: 30041279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary diseases as main causes of pyogenic liver abscess caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Shi SH; Feng XN; Lai MC; Kong HS; Zheng SS
    Liver Int; 2017 May; 37(5):727-734. PubMed ID: 27718321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyogenic liver abscess as the first manifestation of hepatobiliary malignancy.
    Chong VH; Lim KS
    Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):547-50. PubMed ID: 19822502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholangiocarcinoma presenting as pyogenic liver abscess: is its outcome influenced by concomitant hepatolithiasis?
    Jan YY; Yeh TS; Chen MF
    Am J Gastroenterol; 1998 Feb; 93(2):253-5. PubMed ID: 9468254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in the study of occult malignant tumor-related pyogenic liver abscesses in the digestive system].
    Li WZ; Huang JA
    Zhonghua Gan Zang Bing Za Zhi; 2021 Mar; 29(3):275-278. PubMed ID: 33902197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholangiocarcinoma with a paraneoplastic leukemoid reaction mimicking a pyogenic liver abscess.
    Ham H; Kim HY; Seo KJ; Lee SL; Kim CW
    Korean J Intern Med; 2015 Jan; 30(1):110-3. PubMed ID: 25589843
    [No Abstract]   [Full Text] [Related]  

  • 8. [Risk factors of intrahepatic cholangiocarcinoma: a case-control study].
    Zhou HB; Xu QR; Wang H; Zhou DX; Wang H; Wang Q; Zhou SS; Tu QQ; Sun ZQ; Ai L; Wu MC; Hu HP
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):935-9. PubMed ID: 20038337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Segmental cholangiectasia clinically worrisome for cholangiocarcinoma: comparison with recurrent pyogenic cholangitis.
    Zhao L; Hosseini M; Wilcox R; Liu Q; Crook T; Taxy JB; Ferrell L; Hart J
    Hum Pathol; 2015 Mar; 46(3):426-33. PubMed ID: 25600951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late development of cholangiocarcinoma after the treatment of hepatolithiasis.
    Chijiiwa K; Ichimiya H; Kuroki S; Koga A; Nakayama F
    Surg Gynecol Obstet; 1993 Sep; 177(3):279-82. PubMed ID: 8395085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma.
    Kubo S; Kinoshita M; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Hamano G; Ito T; Abue M; Aoki M; Nakagawa K; Unno M; Hijioka S; Fujiyoshi T; Shimizu Y; Mizuguchi T; Shirabe K; Nishie A; Oda Y; Takenaka K; Kobarai T; Hisano T; Saiura A; Numao H; Toda M; Kuwae Y; Nakanuma Y; Endo G
    J Hepatobiliary Pancreat Sci; 2014 Nov; 21(11):809-17. PubMed ID: 25088751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging features of intrahepatic cholangiocarcinoma mimicking a liver abscess: an analysis of 8 cases.
    Liu M; Chen J; Huang R; Huang J; Li L; Li Y; Qin M; Qin W; Nong H; Ding K
    BMC Gastroenterol; 2021 Nov; 21(1):427. PubMed ID: 34772340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique characteristics of pyogenic liver abscesses of biliary origin.
    Shi S; Xia W; Guo H; Kong H; Zheng S
    Surgery; 2016 May; 159(5):1316-24. PubMed ID: 26775071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linoleic acid pathway disturbance contributing to potential cancerization of intrahepatic bile duct stones into intrahepatic cholangiocarcinoma.
    Li J; Lu J; Lv S; Sun S; Liu C; Xu F; Sun H; Yang J; Wang X; Zhong X; Lu J
    BMC Gastroenterol; 2022 May; 22(1):269. PubMed ID: 35637430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical findings among 62 Thais with cholangiocarcinoma.
    Wiwanitkit V
    Trop Med Int Health; 2003 Mar; 8(3):228-30. PubMed ID: 12631312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
    Plentz RR; Malek NP
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia.
    Shin HR; Oh JK; Masuyer E; Curado MP; Bouvard V; Fang Y; Wiangnon S; Sripa B; Hong ST
    Asian Pac J Cancer Prev; 2010; 11(5):1159-66. PubMed ID: 21198257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
    Ehlken H; Schramm C
    Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholangiocarcinoma: descriptive epidemiology and risk factors.
    de Martel C; Plummer M; Franceschi S
    Gastroenterol Clin Biol; 2010 Mar; 34(3):173-80. PubMed ID: 20202771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis.
    Kim YT; Byun JS; Kim J; Jang YH; Lee WJ; Ryu JK; Kim SW; Yoon YB; Kim CY
    Hepatogastroenterology; 2003; 50(49):8-12. PubMed ID: 12629979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.